Why the study?
Does stopping antiplatelet therapy increase cardiovascular complications in patients with coronary stents undergoing non-cardiac surgery?
Population
Patients with coronary stents undergoing non-cardiac surgery
Design
Editorial
Authors
Loading...
This commentary highlights the high risk of cardiovascular complications, particularly stent thrombosis, when stopping antiplatelet therapy before non-cardiac surgery in patients with coronary stents.
Does stopping antiplatelet therapy increase cardiovascular complications in patients with coronary stents undergoing non-cardiac surgery?
This commentary highlights the high risk of cardiovascular complications, particularly stent thrombosis, when stopping antiplatelet therapy before non-cardiac surgery in patients with coronary stents.
Thomas M. Maddox (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: